Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult males over 18 years of age; 2. Histopathologically confirmed prostate cancer; 3. Perfect PSMA PET scan prior to enrolment; 4. Eastern Cooperative Oncology Group score (ECOG PS) 0-2; 5. Patients voluntarily agreed to participate in the study and voluntarily signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. The patients with contraindications to functional imaging; 2. The patients with concomitant combination of other anti-tumor therapies or participation in other interventional clinical trials; 3. The patients who cannot comply with the study for psychological, family, or social reasons. 4. Other conditions deemed unsuitable for enrollment by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival rate;Dose Response Assessment Model; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection rate of oligolesions;Results of radiotherapy strategy optimisation;Radiation therapy-associated toxicity; | — |
Countries
China
Contacts
Department of Abdominal Oncology, West China Hospital of Sichuan University